Exploring LOPHOPHINE. To explore a different substance…

Names:
LOPHOPHINE · Lophophine · 3-Methoxy-4,5-methylenedioxyphenethylamine
IUPAC names:
2-(7-Methoxy-2H-1,3-benzodioxol-5-yl)ethan-1-amine
2-(7-Methoxy-1,3-benzodioxol-5-yl)ethan-1-amine
ID: 95 · Formula: C10H13NO3 · Molecular weight: 195.215
InChI: InChI=1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3

Bruhn, JG; EI-Seedi, HR; Stephanson, N; Beck, O; Shulgin, AT. Ecstasy analogues found in cacti. J. Psychoactive Drugs, 1 Jun 2008, 40 (2), 219–222. 884 kB. http://dx.doi.org/10.1080/02791072.2008.10400635

Shulgin, AT; Sargent, T; Naranjo, C. Structure-activity relationships of one-ring psychotomimetics. Nature, 1 Jan 1969, 221, 537–541. 537 kB. http://dx.doi.org/10.1038/221537a0

Glennon, RA; Kier, LB; Shulgin, AT. Molecular connectivity analysis of hallucinogenic mescaline analogs. J. Pharm. Sci., 1 Jan 1979, 68 (7), 906–907. 252 kB. http://dx.doi.org/10.1002/jps.2600680733

Shulgin, AT. Psychotomimetic drugs: structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 243–333. 2.6 MB. http://dx.doi.org/10.1007/978-1-4757-0510-2_6 Rhodium.

Altun, A; Golcuk, K; Kumru, M; Jalbout, AF. Electron-conformation study for the structure-hallucinogenic activity relationships of phenylalkylamines. Bioorg. Med. Chem., 1 Dec 2003, 11 (24), 3861–3868. 577 kB. http://dx.doi.org/10.1016/S0968-0896(03)00437-1

N-Me-Lophophine
MMDA
α-Et-Lophophine
2C-DMMDA-2
3-Cl-4,5-MDPEA
M
Myristicin
cis-Isomyristicin
Isomyristicin
BOH
MDOH
2C-2 · 2C-MMDA-2
2C-MMDA-4
N-Me-GEA-βk
N-Me-HMPEA-βk
β-HO-MDA
5-HO-N-Me-2-MPEA-βk
2,5-DMPEA-βk
2-HO-5-EPEA-βk
2C-3b
2C-3a
6-MDOH
N-Me-Lophophine
MMDA
α-Et-Lophophine
2C-DMMDA-2
3-Cl-4,5-MDPEA
M
Myristicin
cis-Isomyristicin
Isomyristicin
BOH
MDOH
2C-2 · 2C-MMDA-2
2C-MMDA-4
N-Me-GEA-βk
N-Me-HMPEA-βk
β-HO-MDA
5-HO-N-Me-2-MPEA-βk
2,5-DMPEA-βk
2-HO-5-EPEA-βk
2C-3b
2C-3a
6-MDOH
25 February 2017 · Creative Commons BY-NC-SA ·